Parkwood LLC’s NxStage Medical Inc. NXTM Stock Holding History

Parkwood LLC’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-22,130	Closed	-$555K	–	429
2017 Q2	$555K	Buy	+22,130	New	+$548K	0.08%	166

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Parkwood LLC's NXTM Position: Q3 2017 in Review

Parkwood LLC sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 22,130 shares — an estimated $555K sold.

Parkwood LLC first reported a position in NXTM in Q2 2017 and held it in 1 quarter. The position peaked at $555K in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Parkwood LLC reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Parkwood LLC sold 22,130 NxStage Medical Inc. shares in Q3 2017, an estimated $555K.
Parkwood LLC first reported a position in NxStage Medical Inc. in Q2 2017 and held it in 1 quarter.
Parkwood LLC's NxStage Medical Inc. position peaked at $555K in Q2 2017.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Parkwood LLC's 13F filing for Q3 2017, filed 1 Nov 2017.